SCHEMBL2864433

SCHEMBL2864433

CCCCC/C=C\C/C=C\CCCCCCCC(=O)OC(C(=O)O)C(O)(CC(=O)O)C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.53
PPARG P37231 5/20 0.53
F7 P08709 4/20 0.53
F3 P13726 4/20 0.53
PPARD Q03181 4/20 0.53
PPARA Q07869 4/20 0.53
KDM4E B2RXH2 4/20 0.53
FFAR1 O14842 3/20 0.53
HPGD P15428 3/20 0.53
PTGS1 P23219 2/20 0.53
LMNA P02545 2/20 0.53
CYP3A4 P08684 2/20 0.53
CYP19A1 P11511 2/20 0.53
FABP4 P15090 2/20 0.53
ALOX15 P16050 2/20 0.53
AKR1C3 P42330 2/20 0.53
NR4A2 P43354 2/20 0.53
HSD17B10 Q99714 2/20 0.53
TDP1 Q9NUW8 2/20 0.53
DUSP3 P51452 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2869644 0.90 BLM (0.55) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL2870941 0.90 BLM (0.55) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL2870981 0.90 BLM (0.55) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL2864585 0.90 BLM (0.55) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL23348447 0.80 ALDH1A1 (0.62) ALDH1A1PPARGF7F3PPARD
SCHEMBL6665792 0.80 PRKCA (0.54) ALDH1A1PPARGF7F3PPARD
SCHEMBL2864717 0.79 BLM (0.48) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL2872010 0.79 BLM (0.48) ALDH1A1HPGDLMNAHSD17B10TSHR
SCHEMBL10584630 0.78 PRKCA (0.50) ALDH1A1PPARGF7F3PPARD
SCHEMBL10532716 0.78 FAAH (0.50) ALDH1A1PPARGF7F3PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799631-B1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME SHOWA DENKO KK (JP) 2017-01-25 EP claimed
US-20170312200-A1 AN AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION SHOWA DENKO K.K. (JP) 2017-11-02 US disclosed
EP-3213739-A1 AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION AND ANTI-AGING COMPOSITION Showa Denko K.K. (JP) 2017-09-06 EP disclosed
EP-1799631-B1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME SHOWA DENKO KK (JP) 2017-01-25 EP disclosed
US-7846970-B2 Hydroxycitric acid derivatives and skin external preparations containing the same SHOWA DENKO K.K. (JP) 2010-12-07 US disclosed
US-20070293577-A1 Hydroxycitric Acid Derivatives And Skin External Preparations Using The Same SHOWA DENKO K.K. (JP) 2007-12-20 US disclosed
EP-1799631-A1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME Showa Denko K.K. (JP) 2007-06-27 EP disclosed
WO-2006033476-A1 HYDROXYCITRIC ACID DERIVATIVES AND SKIN EXTERNAL PREPARATIONS CONTAINING THE SAME SHOWA DENKO K.K. (JP) 2006-03-30 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170312200-A1 AN AGENT FOR IMPROVING MITOCHONDRIAL FUNCTION UQCRC1, ACAD9, CYP27B1 ALDH1A1 2001/4885PPARG 663/4885F7 2372/4885
US-20070293577-A1 Hydroxycitric Acid Derivatives And Skin External Preparations Using The Same HAAO, CYP8B1, CUTA ALDH1A1 551/4885PPARG 941/4885F7 411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.